- Home
- AMPG vs ATNM Comparison
AMPG vs ATNM Comparison
Compare AMPG & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- ATNM
- Stock Information
- Founded
- AMPG 2002
- ATNM 2000
- Country
- AMPG United States
- ATNM United States
- Employees
- AMPG N/A
- ATNM N/A
- Industry
- AMPG Telecommunications Equipment
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- ATNM Health Care
- Exchange
- AMPG Nasdaq
- ATNM Nasdaq
- Market Cap
- AMPG 46.7M
- ATNM 49.0M
- IPO Year
- AMPG N/A
- ATNM N/A
- Fundamental
- Price
- AMPG $3.10
- ATNM $1.69
- Analyst Decision
- AMPG Strong Buy
- ATNM Strong Buy
- Analyst Count
- AMPG 1
- ATNM 2
- Target Price
- AMPG $5.00
- ATNM $4.50
- AVG Volume (30 Days)
- AMPG 774.6K
- ATNM 213.8K
- Earning Date
- AMPG 08-14-2025
- ATNM 08-08-2025
- Dividend Yield
- AMPG N/A
- ATNM N/A
- EPS Growth
- AMPG N/A
- ATNM N/A
- EPS
- AMPG N/A
- ATNM N/A
- Revenue
- AMPG $19,312,625.00
- ATNM N/A
- Revenue This Year
- AMPG $114.55
- ATNM N/A
- Revenue Next Year
- AMPG $50.00
- ATNM N/A
- P/E Ratio
- AMPG N/A
- ATNM N/A
- Revenue Growth
- AMPG 58.04
- ATNM N/A
- 52 Week Low
- AMPG $0.64
- ATNM $1.03
- 52 Week High
- AMPG $6.43
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- AMPG 53.83
- ATNM 55.82
- Support Level
- AMPG $2.78
- ATNM $1.39
- Resistance Level
- AMPG $3.72
- ATNM $1.89
- Average True Range (ATR)
- AMPG 0.30
- ATNM 0.12
- MACD
- AMPG 0.01
- ATNM -0.00
- Stochastic Oscillator
- AMPG 47.01
- ATNM 81.08
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.